Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named “Regimen C” for pre-XDR tuberculosis in Niger
- DOI
- 10.3389/ftubr.2025.1718997
- Published
- 2026-01-13
- Container
- Frontiers in Tuberculosis
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/ftubr.2025.1718997,
title = {Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named “Regimen C” for pre-XDR tuberculosis in Niger},
author = {Soumana Boubacar Soumana and Abdourahamane Yacouba and Cheikh Aboubacar Abdoul Lawi and Ibrahim Oumar and Bassirou Souleymane and Alphazazi Soumana and Tapha Ounoussa and Mahamadou Doutchi and Mamane Daou and Souleymane Brah and Eric Adehossi and Saidou Mamadou},
year = {2026},
journal = {Frontiers in Tuberculosis},
doi = {10.3389/ftubr.2025.1718997},
url = {https://doi.org/10.3389/ftubr.2025.1718997}
}RIS
TY - JOUR TI - Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named “Regimen C” for pre-XDR tuberculosis in Niger AU - Soumana Boubacar Soumana AU - Abdourahamane Yacouba AU - Cheikh Aboubacar Abdoul Lawi AU - Ibrahim Oumar AU - Bassirou Souleymane AU - Alphazazi Soumana AU - Tapha Ounoussa AU - Mahamadou Doutchi AU - Mamane Daou AU - Souleymane Brah AU - Eric Adehossi AU - Saidou Mamadou PY - 2026 JO - Frontiers in Tuberculosis DO - 10.3389/ftubr.2025.1718997 UR - https://doi.org/10.3389/ftubr.2025.1718997 ER -
APA
Soumana, S. B., Yacouba, A., Lawi, C. A. A., Oumar, I., Souleymane, B., Soumana, A., Ounoussa, T., Doutchi, M., Daou, M., Brah, S., Adehossi, E., & Mamadou, S. (2026). Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named “Regimen C” for pre-XDR tuberculosis in Niger. Frontiers in Tuberculosis. https://doi.org/10.3389/ftubr.2025.1718997
Source records
- crossref · retrieved 2026-09-25T11:29:37.798Z